Steris's book value per share for the quarter that ended in Dec. 2023 was $64.93.
During the past 12 months, Steris's average Book Value Per Share Growth Rate was 6.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 12.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 14.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Steris was 120.70% per year. The lowest was -8.90% per year. And the median was 8.75% per year.
Steris's current price is $202.80. Its book value per share for the quarter that ended in Dec. 2023 was $64.93. Hence, today's PB Ratio of Steris is 3.12.
During the past 13 years, the highest P/B Ratio of Steris was 4.72. The lowest was 1.81. And the median was 3.25.
Good Sign:
Steris PLC stock PB Ratio (=3.17) is close to 1-year low of 3.06
Steris Book Value per Share Historical Data
The historical data trend for Steris's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Steris's Book Value per Share
For the Medical Devices subindustry, Steris's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's PB Ratio distribution charts can be found below:
* The bar in red indicates where Steris's PB Ratio falls into.
Steris Book Value per Share Calculation
Steris's Book Value Per Share for the fiscal year that ended in Mar. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Steris (NYSE:STE) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Steris Book Value per Share Related Terms
Thank you for viewing the detailed overview of Steris's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STE has been successfully added to your 